Emerging evidence has demonstrated that pulmonary vascular stiffening activates mechanosensitive signaling such as YAP/TAZ signaling which in turn regulates downstream miRNAs and metabolic targets essential for PAH development (Figure 1). The gene discussed is YAP1; the disease is pulmonary arterial hypertension.